(Updated - January 20, 2016 5:31 PM EST) Sarepta Therapeutics (NASDAQ: SRPT) FDA Panel Postponed Due to WeatherUPDATED INFORMATION (as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE